HuGE Literature Finder
|
||
Records 1-41
|
Polymorphisms at activated protein C cleavage sites of factor V: Are they important in the absence of factor V Leiden?
Iranian journal of neurology 2017 Jan 16 (1): 30-33. Kheradmand Ehsan, Haghjooy-Javanmard Shaghayegh, Dehghani Leila, Saadatnia Mohamm |
|
Determinants of acquired activated protein C resistance and D-dimer in breast cancer.
Thrombosis research 2016 Aug 145 78-83. Tinholt Mari, Sandset Per Morten, Mowinckel Marie-Christine, Garred Øystein, Sahlberg Kristine Kleivi, Kristensen Vessela N, Børresen-Dale Anne-Lise, Jacobsen Anne Flem, Skretting Grethe, Iversen Ni |
|
[The preliminary research in paroxysmal nocturnal hemoglobinuria with thrombosis].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2016 Apr 37 (4): 318-23. Du Y L, Long Z B, Xie H Y, Zhuang J L, Han |
|
Prevalence of Factor V Genetic Variants Associated With Indian APCR Contributing to Thrombotic Risk.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2015 Dec . Sharma Amit, Bhakuni Teena, Biswas Arijit, Ranjan Ravi, Kumar Ravi, Kishore Kamal, Mahapatra Manoranjan, Jairajpuri Mohamad Aman, Saxena Re |
|
Factors contributing to APC-resistance in women with recurrent spontaneous miscarriages: Indian perspective.
Blood cells, molecules & diseases 2015 Oct 55 (3): 213-5. Sharma Amit, Singh Neha, Mahapatra Manoranjan, Ranjan Ravi, Kishor Kamal, Saxena Re |
|
Three novel variants in the coagulation factor V gene associated with deep venous thrombosis in Chilean patients with Amerindian ethnic background.
Clinica chimica acta; international journal of clinical chemistry 2015 Apr 444 24-8. Guzmán Neftalí, Larama Giovanni, Ávila Andrés, Salazar Luis |
|
Prevalence of 1691G>A FV mutation in females from Bosnia and Herzegovina--a preliminary report.
Bosnian journal of basic medical sciences / Udruz?enje basic?nih mediciniskih znanosti = Association of Basic Medical Sciences 2013 Feb 13 (1): 31-3. Valjevac Amina, Mehi? Bakir, Kiseljakovi? Emina, Ibrulj Slavka, Garstka Agnieszka, Adler Gra?y |
|
Analysis of Endothelial Protein C Receptor Gene and Metabolic Profile in Prader-Willi Syndrome and Obese Subjects.
Obesity (Silver Spring, Md.) 2011 Dec . Faienza MF, Ventura A, Lauciello R, Crinò A, Ragusa L, Cavallo L, Spera S, Grugni G |
|
Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
British journal of haematology 2011 Jul 154 (2): 241-7. Bergrem Astrid, Dahm Anders Erik Astrup, Jacobsen Anne Flem, Mowinckel Marie-Christine, Sandvik Leiv, Sandset Per Mort |
|
[Study on activated protein C resistance and disordered coagulation in patients with myeloproliferative neoplasms].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2011 Mar 32 (3): 187-90. Bai Jie, Xue Yang-ping, Xu Xian-hui, Zhang Lei, Tian Meng-su, Shen Lin, Zhang Hong-yun, Yang Ren-c |
|
Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women.
Journal of pregnancy 2011 2011 232840. Sedano-Balbás Sara, Lyons Mark, Cleary Brendan, Murray Margaret, Gaffney Geraldine, Maher Majel |
|
Frequency of prothrombotic risk factors in patients with deep venous thrombosis and controls: their implications for thrombophilia screening in Chilean subjects.
Genetic testing and molecular biomarkers 2010 Oct 14 (5): 599-602. Guzmán Neftalí, Salazar Luis |
|
A study on thrombophilic factors in Italian Behcet's patients.
Joint, bone, spine : revue du rhumatisme 2010 Jul 77 (4): 330-4. Caramaschi Paola, Poli Giovanni, Bonora Adriana, Volpe Alessandro, Tinazzi Ilaria, Pieropan Sara, Bambara Lisa M, Biasi Domeni |
|
Acquired and inherited risk factors for the developing of venous thromboembolism in cancer patients receiving adjuvant chemotherapy: A prospective trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 May 27 (15_suppl): 9572. Labianca R, Mandalà M, Barni S, Falanga |
|
Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007 Oct 18 (7): 603-10. Gessoni Gianluca, Valverde Sa |
|
The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2007 Apr 13 (2): 166-71. Kabukcu Sibel, Keskin Nazan, Keskin Ali, Atalay Er |
|
Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
American journal of hematology 2006 Dec 81 (12): 933-7. Torres J D, Cardona H, Alvarez L, Cardona-Maya W, Castañeda S A, Quintero-Rivera F, Cadavid A, Bedoya G, Tobón |
|
Plasma protein S activity correlates with protein S genotype but is not sensitive to identify K196E mutant carriers.
Journal of thrombosis and haemostasis : JTH 2006 Sep 4 (9): 2010-3. Kimura R, Sakata T, Kokubo Y, Okamoto A, Okayama A, Tomoike H, Miyata |
|
Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.
European journal of gastroenterology & hepatology 2005 Jul 17 (7): 739-44. Mahmood Asif, Needham Jane, Prosser Jeanne, Mainwaring Jason, Trebble Tim, Mahy Gillian, Ramage Jo |
|
Prevalence of factor V Leiden and prothrombin G20210A gene mutation.
Saudi medical journal 2005 Apr 26 (4): 580-3. Irdem Ahmet, Devecioglu Celal, Batun Sabri, Soker Murat, Sucakli Iclal |
|
Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2004 Aug 2 (8): 1305-10. Uitte de Willige S, Van Marion V, Rosendaal F R, Vos H L, de Visser M C H, Bertina R |
|
Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk.
Thrombosis and haemostasis 2004 May 91 (5): 905-11. Medina Pilar, Navarro Silvia, Estellés Amparo, Vayá Amparo, Woodhams Barry, Mira Yolanda, Villa Piedad, Migaud-Fressart Martine, Ferrando Fernando, Aznar Justo, Bertina Rogier M, España Francis |
|
A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis.
Blood 2004 Feb 103 (4): 1311-8. Saposnik Beatrice, Reny Jean-Luc, Gaussem Pascale, Emmerich Joseph, Aiach Martine, Gandrille Soph |
|
[Factor V Leiden and the Slovak population].
Vnitr?ní lékar?ství 2003 Nov 49 (11): 845-50. Hudecek J, Dobrotová M, Hybenová J, Ivanková J, Melus V, Pullmann R, Kubisz |
|
Factor V Leiden in pregnancies complicated by placental abruption.
BJOG : an international journal of obstetrics and gynaecology 2003 May 110 (5): 462-6. Procházka Martin, Happach Catharina, Marsál Karel, Dahlbäck Björn, Lindqvist Pelle |
|
No association between thrombosis and factor V gene polymorphisms in Chinese Han population.
Thrombosis and haemostasis 2003 Mar 89 (3): 446-51. Yanqing Hu, Fangping Chen, Qinzhi Xie, Zaifu Jian, Guangping Wang, Xiaoxia Zuo, Xiaoqun Pu, Xiaob |
|
Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk.
Thrombosis and haemostasis 2003 Mar 89 (3): 452-7. Vayá Amparo, Mira Yolanda, Mateo Jose, Falco Cristina, Villa Piedad, Estelles Amparo, Corella Dolores, Fontcuberta Jordi, Aznar Jus |
|
G-455A polymorphism of the fibrinogen beta gene and deep vein thrombosis.
European journal of clinical investigation 2002 Oct 32 (10): 755-8. Renner W, Cichocki L, Forjanics A, Köppel H, Gasser R, Pilger |
|
[Activated protein C resistance and deep venous thrombosis in pregnancy].
Ceská gynekologie / Ceská lékarská spolecnost J. Ev. Purkyne 2002 Sep 67 (5): 251-4. Procházka M, Krcová V, Hrachovec P, Kudela M, Slavík |
|
Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
American journal of hematology 2002 Sep 71 (1): 1-6. Ruggeri Marco, Gisslinger Heinz, Tosetto Alberto, Rintelen Claudia, Mannhalter Christine, Pabinger Ingrid, Heis Navide, Castaman Giancarlo, Missiaglia Edoardo, Lechner Klaus, Rodeghiero Frances |
|
Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
Thrombosis and haemostasis 2002 Jul 88 (1): 5-11. Curvers Joyce, Thomassen M Christella L G D, Rimmer Janet, Hamulyak Karly, van der Meer Jan, Tans Guido, Preston F Eric, Rosing J |
|
Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation.
Thrombosis research 2002 Jul 107 (1-2): 7-11. Gouin-Thibault I, Arkam R, Nassiri S, de la Tourette A, Conard J, Horellou M H, Elalamy I, Samama M |
|
Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002 Apr 13 (3): 187-92. Zangari M, Saghafifar F, Anaissie E, Badros A, Desikan R, Fassas A, Mehta P, Morris C, Toor A, Whitfield D, Siegel E, Barlogie B, Fink L, Tricot |
|
Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
Thrombosis research 2002 Apr 106 (1): 59-62. Antovic Jovan P, Blombäck Margare |
|
Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001 Oct 12 (7): 569-76. Quincampoix J C, Legarff M, Rittling C, Andiva S, Toulon |
|
Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
Thrombosis and haemostasis 2001 Sep 86 (3): 804-8. Castaman G, Tosetto A, Simioni M, Ruggeri M, Madeo D, Rodeghiero |
|
Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage.
Human reproduction (Oxford, England) 2001 May 16 (5): 961-5. Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K, Regan |
|
Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers.
The British journal of dermatology 2001 Mar 144 (3): 546-8. Gaber Y, Siemens H J, Schmeller |
|
Factor V Arg306 --> Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese.
Thrombosis and haemostasis 2001 Feb 85 (2): 270-3. Shen M C, Lin J S, Tsay |
|
Factor V Leiden and its relation to left ventricular thrombus in acute myocardial infarction.
Acta cardiologica 2001 Feb 56 (1): 1-6. Celik S, Ovali E, Baykan M, Uçar F, Erdöl C, Durmu? I, Kaplan |
|
Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion.
Retina (Philadelphia, Pa.) 2001 21 (2): 161-6. Johnson T M, El-Defrawy S, Hodge W G, Leonard B C, Kertes P J, Taylor SAM , Lillicrap D |
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 29, 2019
- Content source: